Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
Titel:
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
Auteur:
Schmitz, S. Kaminsky-Forrett, M.-C. Henry, S. Zanetta, S. Geoffrois, L. Bompas, E. Moxhon, A. Mignion, L. Guigay, J. Knoops, L. Hamoir, M. Machiels, J.-P.